Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Int J Mol Sci ; 24(20)2023 Oct 13.
Artigo em Inglês | MEDLINE | ID: mdl-37894837

RESUMO

This study performs an analysis that will enable the evaluation of the quality, durability, and structure of repaired cartilaginous extracellular matrix tissue using an autologous-based particulated autograft cartilage and platelet-rich plasma treatment (PACI + PRP). A single-blind controlled experiment was conducted on 28 sheep to evaluate the efficacy of the PACI + PRP treatment for cartilage defects. Full-thickness 8 mm diameter defects were created in the weight-bearing area of both knees. The right knees received PACI + PRP. The left knees were treated with Ringer's lactate solution (RLS) or hyaluronic acid (HA) injections. Sheep were euthanized at 9- or 18-months post-surgery. An extensive immunohistochemical analysis was performed to assess collagen types (I, II, III, V, VI, IX, X, XI) and aggrecan positivity. A semiquantitative scoring system provided a detailed evaluation of immunostaining. Collagens and aggrecan scores in the PACI + PRP groups were similar to healthy cartilage. Significant differences were found in collagens associated with matrix maturity (II and V), degradation (IX), structure and mechanics (VI), and hypertrophy (X) between healthy cartilage and RLS- or HA-repaired cartilage. The PACI + PRP treatment advanced the repair cartilage process in chondral defects with mature hyaline cartilage and enhanced the structural and mechanical qualities with better consistent cartilage, less susceptible to degradation and without hypertrophic formation over time.


Assuntos
Doenças das Cartilagens , Cartilagem Articular , Plasma Rico em Plaquetas , Animais , Ovinos , Cartilagem Articular/cirurgia , Agrecanas/genética , Agrecanas/metabolismo , Método Simples-Cego , Doenças das Cartilagens/metabolismo , Plasma Rico em Plaquetas/metabolismo , Ácido Hialurônico/metabolismo , Colágeno/metabolismo
2.
Knee Surg Sports Traumatol Arthrosc ; 31(7): 2944-2955, 2023 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-36598512

RESUMO

PURPOSE: Articular cartilage is vulnerable to multiple types of damage and it has limited reparative and regenerative capacities due to its absence of vascularity. Although a large number of therapeutic strategies exist to treat chondral defects, they have some limitations, such as fibrocartilage formation. Therefore, the goal of the present study was to evaluate the chondrogenic regenerative properties of an autologous-made matrix of particulated cartilage and platelet-rich plasma (PACI + PRP) implantation for the treatment of full-thickness chondral defects in sheep. METHODS: A full-thickness 8 mm diameter cartilage defect was created in the weight-bearing area of the medial femoral condyle in both knees of 16 sheep. The right knees of all animals were treated with particulated autograft cartilage implantation and platelet-rich plasma, while the left knees were injected with Ringer's lactate solution or hyaluronic acid. The sheep were killed 9 or 18 months after surgery. Macroscopic evaluations were performed using three different scoring systems, and histopathological evaluations were performed using a modified scoring system based on different scoring systems. RESULTS: The PACI + PRP groups showed statistically significant differences in the percentage of defect repair and chondrocytes in the newly formed cartilage tissue at 18 months compared to 9 months. CONCLUSIONS: The results suggest that macroscopic appearance, histological structure and chondrocyte repair were improved when using PACI + PRP treatment for chondral defects, producing an outcome similar to the surrounding healthy cartilage. PACI + PRP is a totally autologous, easy, and unexpensive treatment that can be performed in one-step procedure and is useful as a therapeutic option for knee chondral defects.


Assuntos
Doenças das Cartilagens , Cartilagem Articular , Plasma Rico em Plaquetas , Animais , Ovinos , Articulação do Joelho/cirurgia , Cartilagem Articular/patologia , Doenças das Cartilagens/patologia , Condrócitos/transplante
3.
Res Vet Sci ; 105: 36-40, 2016 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-27033905

RESUMO

Thirty-two dogs were used in this prospective, randomized, clinical and double-blinded study. Dexmedetomidine was administered at 1 µg/kg IV, and randomly each dog received dexketoprofen 1 mg/kg IV (group DK) or methadone 0.2 mg/kg IV (group M). Dogs were induced with propofol and maintained with isoflurane in 100% oxygen. During surgery, the isoflurane concentration was changed depending on clinical signs of depth of anesthesia. Fentanyl and propofol could be used as required. Qualities of sedation and recovery were evaluated. A generalized linear mixed model or Mann-Whiney U test was used, and P<0.05 was considered statistically significant. No significant differences were observed between groups in the qualities of sedation and recovery, isoflurane concentration and in the total amount of fentanyl and propofol used intraoperatively. This study shows that the administration of dexketoprofen at 1 mg/kg IV at premedication required a similar isoflurane concentration to maintain anesthesia as methadone at 0.2 mg/kg IV during orthopedic surgery in dogs. Further analgesia is recommended intraoperatively, because of the need of fentanyl and propofol in same animals in both groups.


Assuntos
Analgésicos Opioides/uso terapêutico , Anti-Inflamatórios não Esteroides/uso terapêutico , Cães/cirurgia , Cetoprofeno/análogos & derivados , Metadona/uso terapêutico , Ortopedia/veterinária , Pré-Medicação/veterinária , Trometamina/uso terapêutico , Analgésicos Opioides/administração & dosagem , Anestésicos Inalatórios/administração & dosagem , Anestésicos Inalatórios/uso terapêutico , Animais , Anti-Inflamatórios não Esteroides/administração & dosagem , Método Duplo-Cego , Isoflurano/administração & dosagem , Isoflurano/uso terapêutico , Cetoprofeno/administração & dosagem , Cetoprofeno/uso terapêutico , Metadona/administração & dosagem , Estudos Prospectivos , Trometamina/administração & dosagem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA